独立董事候选人声明与承诺 本人刘玉珍，已充分了解并同意由提名人中泰证券股份有限公司 董事会提名为中泰证券股份有限公司第三届董事会独立董事候选人。 本人公开声明，本人具备独立董事任职资格，保证不存在任何影响本 人担任中泰证券股份有限公司独立董事独立性的关系，具体声明并承 诺如下： 一、本人具备上市公司运作的基本知识，熟悉相关法律、行政法 规、部门规章及其他规范性文件，具有 5 年以上经济等履行独立董事 职责所必需的工作经验。 本人已经参加培训并取得证券交易所认可的相关培训证明材料。 二、本人任职资格符合下列法律、行政法规和部门规章以及公司 规章的要求： （一）《中华人民共和国公司法》关于董事任职资格的规定； （二）《中华人民共和国公务员法》关于公务员兼任职务的规定 （如适用）； （三）中国证监会《上市公司独立董事管理办法》、上海证券交 易所自律监管规则以及公司章程有关独立董事任职资格和条件的相 关规定； （四）中共中央纪委、中共中央组织部《关于规范中管干部辞去 公职或者退（离）休后担任上市公司、基金管理公司独立董事、独立 1 监事的通知》的规定（如适用）； （五）中共中央组织部《关于进一步规范党政领导干部在企业 ...

证券代码：600918 证券简称：中泰证券 公告编号：2024-058 中泰证券股份有限公司 2024年度第二期短期融资券兑付完成公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中泰证券股份有限公司（以下简称"本公司"）于 2024 年 2 月 1 日成功发 行了中泰证券股份有限公司 2024 年度第二期短期融资券（以下简称"本期短期 融资券"），本期短期融资券发行规模为人民币 20 亿元，票面利率为 2.45%， 短期融资券期限为 307 天，兑付日期为 2024 年 12 月 5 日。 2024 年 12 月 5 日，本公司兑付了本期短期融资券本息共计人民币 2,041,101,092.90 元。 特此公告。 中泰证券股份有限公司董事会 2024 年 12 月 5 日 ...

Industry Overview - The pharmaceutical sector experienced a strong rebound in early November after being at a low level, followed by fluctuations in line with the broader market [1] - The sector's performance was driven by policy catalysts such as medical insurance prepayments and the release of the medical insurance catalog, with notable performance in pharmaceutical commerce and innovative drug sub-sectors [2] - The easing of medical insurance policies, a core factor suppressing the sector, along with industry comparisons and fund holdings, suggests significant upward potential for the sector [2] Investment Opportunities - High-growth areas: Despite valuation pressures in recent years, sectors like innovative drugs, generic-innovative combinations, and GLP-1 are expected to benefit from policy support and improved risk appetite, opening up valuation space [2] - Turnaround opportunities: The pharmaceutical sector has seen a trend of recovery, particularly in active pharmaceutical ingredients (APIs), low-consumption products, and upstream segments. In the coming year, CRO/CDMO, upstream, ICL, and equipment bidding are expected to show clear inflection points [2] - Stable performance: The sector has shown rotational performance, with structural opportunities driven by strong earnings. Companies in traditional Chinese medicine and blood products are expected to maintain robust performance [2] - Thematic and event-driven opportunities: During the prolonged earnings vacuum period, short-term risk appetite may increase, creating opportunities from mergers and acquisitions, policy improvements, and other events [2] Key Companies to Watch - Companies such as WuXi AppTec, Dong-E-E-Jiao, and Betta Pharmaceuticals are highlighted for potential investment opportunities [3]

证券代码：600918 证券简称：中泰证券 公告编号：2024-057 中泰证券股份有限公司 关于为境外全资子公司中泰金融国际有限公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 一、担保情况概述 （一）担保基本情况 为增强境外全资子公司中泰国际实力，促进境外业务发展，公司于2024年 11月28日与招商银行股份有限公司济南分行（以下简称"招商银行济南分行"） 签署《担保合作协议》，以内保外贷方式向招商银行济南分行申请为中泰国际获 取境外银行借款开具保函，担保总额为1.50亿港元，担保期限为12个月。截至 本公告披露之日，公司为中泰国际提供的担保余额为10亿港元（含本次担保）。 （二）本次担保事项履行的内部决策程序 2．成立日期：2011年6月22日 3．注册地点：香港 4．主要办公地点：香港德辅道中189号李宝椿大厦19楼 2023年3月30日，公司第二届董事会第六十六次会议审议并通过了《关于发 1 被担保人名称：中泰金融国际有限公司（以下简称"中泰国际"） 被担保人是否为公司关联方：否，为 ...

证券代码：600918 证券简称：中泰证券 公告编号：2024-056 中泰证券股份有限公司 2024年度第五期短期融资券发行结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中泰证券股份有限公司 2024 年度第五期短期融资券已于 2024 年 11 月 19 日 发行完毕，现将发行结果公告如下： | 名称 | | | | 中泰证券股份有限公司 | 2024 | 年度第五期短期融资券 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 简称 | | | | 24 | 中泰证券 CP005 | | | | | | | 代码 | 072410226 | | | | 期限 | | 301 | 天 | | | | 起息日 | 2024 年 | 11 | 月 20 | 日 | 兑付日 | 2025 | 年 | 9 月 | 17 | 日 | | 计划发行 总额 | 20 亿元 | | | | 实际发行总额 | | 20 | ...

Group 1: Company Overview - Zhongtai Securities is a comprehensive securities firm approved by the China Securities Regulatory Commission, offering a wide range of services including investment banking, wealth management, research, institutional business, investment business, credit business, asset management, international business, and futures business [1]. Group 2: Asset Management Business - As of June 30, 2024, Zhongtai Asset Management had an asset management scale of CNY 122.14 billion, with public fund business size reaching CNY 42.26 billion [2]. - Wanji Fund, a subsidiary, managed a total of 152 public funds with a combined scale of CNY 467.83 billion, reflecting an increase of CNY 73.63 billion, or 18.68%, compared to the end of the previous year [2]. Group 3: Financial Digital Transformation - The company has made significant progress in financial digital transformation, establishing systems for group control, financial sharing, management accounting, corporate travel, treasury, and electronic accounting archives [2]. - Future focus will be on financial intelligence and "big finance" management goals, aiming to enhance financial management transformation and efficiency [2]. Group 4: IPO Policy Perspective - The current IPO policy is seen as a crucial part of the deepening reform of the registration system, necessary for balancing the investment and financing sides [2]. - The company aims to build a significant investment banking business system with industry influence, enhancing professional capabilities and client service to ensure project quality [2].

Core Viewpoint - The event marked a strategic collaboration between Weifang Municipal Government and Zhongtai Securities, focusing on enhancing local economic development and capital market engagement [1] Group 1: Strategic Collaboration - Weifang Municipal Government signed a comprehensive strategic cooperation agreement with Zhongtai Securities [1] - The collaboration aims to support local state-owned enterprises, listed companies, and domestic and foreign listing candidates [1] Group 2: Brand and Initiatives Launch - The "Gongcheng Zhixing" brand was officially launched during the event [1] - The ceremony included the unveiling of the Weifang Operation Center of Qilu Equity Exchange [1] - A concentration of "specialized, refined, distinctive, and innovative" enterprises was facilitated with a dedicated listing board and the initiation of the "Listing Cloud Ladder Plan" for Weifang [1] Group 3: Expert Insights - Experts from Zhongtai Securities delivered presentations on macroeconomic policies, industrial development, and capital market trends [1]

Core Viewpoint - The report from Zhongtai Securities indicates a significant transformation in the electrolytic aluminum sector, driven by changes in supply and demand dynamics, leading to a revaluation of resource attributes and price restructuring in the entire aluminum industry chain [1] Supply Side - The reliance on imported bauxite is increasing, and its concentration is rising, indicating that bauxite is no longer an absolute surplus resource, and its resource value is undergoing reassessment [1] - Domestic electrolytic aluminum production capacity is nearing its ceiling, while overseas incremental capacity is limited and costly, highlighting the "resource-like" attributes of the electrolytic aluminum segment [1] Demand Side - The ongoing counter-cyclical adjustments in the domestic market are expected to alleviate the drag from traditional demand [1] - Demand from the new energy sector, including electric vehicles and photovoltaics, is anticipated to drive a trend of recovery in electrolytic aluminum demand, with a growth rate of approximately 2% to 3% [1] Industry Outlook - The judgment is maintained that the prosperity of the electrolytic aluminum industry chain may exhibit a spiral upward trend, as profound changes on both supply and demand sides are reshaping the entire aluminum industry chain under the revaluation of resource attributes [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于 2024 年 11 月 5 日（星期二）至 11 月 11 日（星期一）16:00 前登 录上证路演中心网站首页点击 " 提问预征集 " 栏目或通过公司邮箱 ztsdb@zts.com.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行回 答。 中泰证券股份有限公司（以下简称"公司"）于 2024 年 10 月 31 日披露公 司 2024 年第三季度报告，为便于广大投资者更全面深入地了解公司 2024 年第 三季度经营成果、财务状况，公司计划于 2024 年 11 月 12 日下午 13:00-14:00 举行 2024 年第三季度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 证券代码：600918 证券简称：中泰证券 公告编号：2024-054 中泰证券股份有限公司 关于召开2024年第三季度业绩说明会的公告 四、投资者参加方式 （一）投资者可在 2024 年 11 月 12 日下午 13:00-14:00，通过互联网登录上 证 ...